SCHEMBL5191126

SCHEMBL5191126

NC(=O)CC1CN(C(=O)OCc2ccccc2)CCN1Cc1ccc(Cl)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.48
CYP2C19 P33261 1/20 0.48
OPRK1 P41145 2/20 0.47
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ALDH1A1 P00352 1/20 0.43
CA1 P00915 4/20 0.42
CA2 P00918 4/20 0.42
CA4 P22748 4/20 0.42
CA9 Q16790 4/20 0.42
LMNA P02545 1/20 0.42
POLB P06746 1/20 0.42
OPRD1 P41143 1/20 0.41
GRM5 P41594 1/20 0.40
P2RX4 Q99571 1/20 0.40
PARP1 P09874 1/20 0.40
DRD2 P14416 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29121490 0.82 SMN1; SMN2 (0.52) SMN1; SMN2CYP2C19OPRK1NPC1RAB9A
SCHEMBL16637186 0.81 SMN1; SMN2 (0.55) SMN1; SMN2CYP2C19OPRK1NPC1RAB9A
SCHEMBL28166666 0.78 SMN1; SMN2 (0.56) SMN1; SMN2CYP2C19OPRK1NPC1RAB9A
SCHEMBL5194848 0.78 OPRK1 (0.46) SMN1; SMN2CYP2C19OPRK1KMT2AALDH1A1
SCHEMBL4329419 0.76 PDK1 (0.56) SMN1; SMN2CYP2C19OPRK1NPC1RAB9A
SCHEMBL5214033 0.75 SIGMAR1 (0.49) POLB
SCHEMBL10681973 0.75 SIGMAR1 (0.55) MEN1KMT2AALDH1A1LMNAPOLB
SCHEMBL5193908 0.74 LMNA (0.42) CYP2C19MEN1KMT2ANPSR1LMNA
SCHEMBL29121531 0.73 SMN1; SMN2 (0.52) SMN1; SMN2CYP2C19NPC1RAB9AMEN1
SCHEMBL27806690 0.73 ALDH1A1 (0.59) SMN1; SMN2CYP2C19NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0968206-B8 N-HETEROCYCLIC DERIVATIVES AS NOS INHIBITORS BERLEX INC (US) 2007-01-24 EP claimed
EP-0968206-A1 N-HETEROCYCLIC DERIVATIVES AS NOS INHIBITORS BERLEX LABORATORIES, INC. (US) 2000-01-05 EP claimed
WO-1998037079-A1 N-HETEROCYCLIC DERIVATIVES AS NOS INHIBITORS BERLEX LABORATORIES, INC. (US) 1998-08-27 WO claimed